Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

(2015)   HIV MEDICINE

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

(2014) Colette J Smith et al.   LANCET

Liver Stiffness Is Associated With Monocyte Activation in HIV-Infected Ugandans Without Viral Hepatitis

(2013) Andrew D. Redd et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Antiretroviral Therapy Reduces the Rate of Hepatic Decompensation Among HIV- and Hepatitis C Virus–Coinfected Veterans

(2013) Jeffrey P. Anderson et al.   CLINICAL INFECTIOUS DISEASES

Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study

(2013) R Weber et al.   HIV MEDICINE

Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study

(2012) Abdel G Babiker et al.   Clinical Trials

The Effect of HIV Infection, Immunodeficiency, and Antiretroviral Therapy on the Risk of Hepatic Dysfunction

(2012) William J. Towner et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

HIV Monoinfection Is Associated With Increased Aspartate Aminotransferase-to-Platelet Ratio Index, a Surrogate Marker for Hepatic Fibrosis

(2012) Jennifer C. Price et al.   JOURNAL OF INFECTIOUS DISEASES

Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection

(2011) M. Mendeni et al.   CLINICAL INFECTIOUS DISEASES

Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings

(2010) Eugenia Vispo et al.   AIDS

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients

(2010) Michelle DallaPiazza et al.   BMC INFECTIOUS DISEASES

Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years

(2010) D. Roulot et al.   GUT

Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers

(2009) M. Sánchez-Conde et al.   JOURNAL OF VIRAL HEPATITIS

Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C

(2008) Ashwin Balagopal et al.   GASTROENTEROLOGY

Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis

(2008) Mireen Friedrich–Rust et al.   GASTROENTEROLOGY

Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy

(2008) Patrick Ingiliz et al.   HEPATOLOGY

Non-invasive evaluation of liver fibrosis using transient elastography

(2008) Laurent Castera et al.   JOURNAL OF HEPATOLOGY

HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

(2008) J. T. Blackard et al.   JOURNAL OF VIRAL HEPATITIS